On June 23, 2022, the National Medical Product Administration (NMPA) issued two standards, NMPAB/T 1011-2022 โIdentification Specification for Drug Traceability Codeโ and NMPAB/T 1012-2022 โDisplay Specification for Consumer Query Results of Drug Traceabilityโ. It is aimed to promote the construction of drug information traceability system, and guide drug marketing license holders and manufacturers to carry out drug traceability code identification and drug traceability consumer query results display from the perspective of technical implementation. The โSpecifications for Drug Traceability Code Markingโ was implemented from June 23, 2023, and the โSpecifications for Displaying the Results of Drug Traceability Consumer Inquiryโ was implemented from the date of issuance.
Currently two coding system are still issued in China – the global GS1 standard and the Electronic Drug Monitoring Code (EDMC) standard that is unique to China:
Current activities to move forward with the use of GS1 standards.